Acea Bio

For profitWebsite ↗

Also known as: Acea Bio (Hangzhou) Co., Ltd. | ACEA Therapeutics, Inc. | Hangzhou ACEA Pharmaceutical Research Co., Ltd. | Hangzhou ACEA Pharmaceutical Research Co.,Ltd. | Zhejiang ACEA Pharmaceutical Co. Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2009

Last known activity

Mar 31, 2024

Acquired by Sorrento Therapeutics, Inc. on Jun 3, 2021

Timeline

2000s

Jun 1, 2002
Acea Bio— Founded

2020s

Jun 3, 2021
Sorrento Therapeutics, Inc.— Acquired By

Drugs by trial phase (11 distinct, 19 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (22)

NCT05947344Lead sponsorPhase 1Mar 31, 2024
NCT06044233Lead sponsorPhase 1Sep 28, 2023
NCT05754411Lead sponsorPhase 1May 15, 2023
NCT05716425Lead sponsorPhase 3Feb 8, 2023
NCT05685719Lead sponsorPhase 1Jan 4, 2023
NCT05565807Lead sponsorPhase 1/Phase 2Dec 23, 2022
NCT05523739Lead sponsorPhase 1Sep 16, 2022
NCT03856697Lead sponsorPhase 3Mar 31, 2019
NCT03878303Lead sponsorPhase 1Nov 28, 2018
NCT03878303CollaboratorPhase 1Nov 28, 2018
NCT03058094Lead sponsorPhase 3Dec 1, 2017
NCT03300115Lead sponsorPhase 2May 18, 2017
NCT03300115CollaboratorPhase 2May 18, 2017
NCT03060850Lead sponsorPhase 1Feb 28, 2017
NCT03001609Lead sponsorPhase 1Nov 1, 2016

Details

Founded: San Diego, CA, US Jun 1, 2002
Last known activity: Mar 31, 2024